Gastric Cancer Clinical Trials

A listing of Gastric Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 47 clinical trials
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Phase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.

bone marrow procedure
erbb2
cancer
HER2
breast cancer
  • 0 views
  • 18 Sep, 2021
  • 3 locations
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors

This is a Phase 1b/2, open-label, multicenter study of DSP-7888 Dosing Emulsion in combination with checkpoint inhibitors (nivolumab or pembrolizumab) in adult patients with solid tumors, that consists of 2 parts: dose search part of the study (Phase 1b and Phase 1b Enrichment Cohort) and the dose expansion part of …

solid tumour
pembrolizumab
international normalized ratio
colony stimulating factor
primary cancer
  • 59 views
  • 15 Sep, 2021
  • 25 locations
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

This is a study to determine the maximum tolerated dose (MTD) for CDX-1140 (CD40 antibody), either alone or in combination with CDX-301 (FLT3L), pembrolizumab, or chemotherapy and to further evaluate its tolerability and efficacy in expansion cohorts once the MTD is determined.

large b-cell lymphoma
metastatic pancreatic adenocarcinoma
gemcitabine
pembrolizumab
lymphoma
  • 399 views
  • 17 Sep, 2021
  • 11 locations
Testing the Addition of an Anti-cancer Drug BAY 1895344 to the Usual Chemotherapy Treatment (Cisplatin or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

This phase I trial identifies the best dose, possible benefits and/or side effects of BAY 1895344 in combination with chemotherapy in treating patients with solid tumors or urothelial cancer that has spread to other places in the body (advanced). BAY 1895344 may stop the growth of tumor cells by blocking …

  • 0 views
  • 17 Sep, 2021
  • 1 location
Testing the Combination of Two Anti-cancer Drugs DS-8201a and AZD6738 for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene The DASH Trial

The dose escalation phase of this trial identifies the best dose and safety of ceralasertib (AZD6738) when given in combination with trastuzumab deruxtecan (DS-8201a) in treating patients with solid tumors that have a change (mutation) in the HER2 gene or protein and have spread to other places in the body …

  • 0 views
  • 15 Sep, 2021
  • 7 locations
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Open-label, Phase I-II, first-in-human (FIH) study for A166 monotherapy in HER2-expressing or amplified patients who progressed on or did not respond to available standard therapies. Patients must have documented HER2 expression or amplification. The patient must have exhausted available standard therapies. Patients will receive study drug as a single IV …

platelet count
total bilirubin
hysterectomy
metastatic cancer
serum bilirubin
  • 268 views
  • 09 Sep, 2021
  • 10 locations
Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused pandemic since outbreak in 2020. Patients with cancers may be at higher risk than those without cancer for coronavirus disease 2019 (COVID-19). At present, limited data are available on the safety and immunogenicity of COVID-19 vaccination for patients with cancer.

cancer
vaccination
covid-19
hepatocellular carcinoma
  • 0 views
  • 09 Sep, 2021
  • 1 location
VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)

Background Gastrointestinal cancer is one of the most common cancers worldwide. Researchers think an unmet need exists to understand and improve treatment options. They want to see if a combination of drugs can help people with metastatic colorectal cancer. Objective To see if using a combination of VB-111 and nivolumab …

platelet count
metastasis
KRAS
metastatic colorectal cancer
liver metastasis
  • 32 views
  • 12 Sep, 2021
  • 1 location
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer

cancers. They want to learn about changes these cause in the body and about the genes involved. Objective -To gather data about hereditary gastric cancer.

CDH1
cancer
gastric adenocarcinoma
gastric neoplasm
gastric cancer
  • 192 views
  • 19 Sep, 2021
  • 1 location
Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt

Subepithelial lesions (SEL) are incidentally observed in the stomach of about 0.3% of middle-aged men and women; half of these are neoplastic. The incidence of subepithelial tumors (SET) of gastrointestinal (GI) origin has risen twofold to fivefold within the past 30 years.The etiology of most SMTs cannot easily be determined …

endoscopy
ct scan
endoscopic ultrasound
  • 0 views
  • 09 Sep, 2021
  • 1 location